Fumarate Fesoterodine fumarate Fesoterodine

CAS 286930-03-8 MFCD12756004

化学结构图

286930-03-8
SMILES: CC(C)C(=O)OC1C=CC(CO)=CC=1[C@@H](CCN(C(C)C)C(C)C)C1C=CC=CC=1.OC(=O)/C=C/C(O)=O |&1:14|

化学属性

Mol. FormulaC30H41NO7
Mol. Weight527.65

别名和识别编码

Chemical NameFumarate Fesoterodine fumarate
CAS Number286930-03-8
Synonym 2-Methylpropanoic Acid 2-[(1R)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]
Chemical Name TranslationFesoterodine
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

分类

  • Amines
  • Aromatics
  • Pharmaceuticals
  • Intermediates & Fine Chemicals,

产品应用

  • (R)-Fesoterodine Fumarate is a muscarinic receptor antagonist for the treatment of Lower Urininary Tract Symptoms (LUTS).

相关文献及参考

  • [2]. Didem Yilmaz-Oral, et al. The Beneficial Effect of Fesoterodine, a Competitive Muscarinic Receptor Antagonist on Erectile Dysfunction in Streptozotocin-induced Diabetic Rats.
  • [3]. Peter Ney, et al. Pharmacological Characterization of a Novel Investigational Antimuscarinic Drug, Fesoterodine, in Vitro and in Vivo. BJU Int. 2008 Apr;101(8):1036-42.
  • [4]. Martin C Michel, et al. Fesoterodine: A Novel Muscarinic Receptor Antagonist for the Treatment of Overactive Bladder Syndrome. Expert Opin Pharmacother. 2008 Jul;9(10):1787-96.
  • Rogers, D., et al.: Pharmacotherapy, 20, 1092 (2000),
  • [1]. Ellsworth P, et al. Fesoterodine for the treatment of urinary incontinence and overactive bladder. Ther Clin Risk Manag. 2009;5:869-76. Epub 2009 Nov 18.
  • [1]. Ellsworth P, et al. Fesoterodine for the treatment of urinary incontinence and overactive bladder. Ther Clin Risk Manag. 2009;5:869-76. Epub 2009 Nov 18.
  • [2]. Didem Yilmaz-Oral, et al. T

系列性分类

  1. Medical Research Areas
  2. GPCR & G Protein
  3. mAChR  (毒蕈碱型乙酰胆碱受体)

相关产品推荐